| 000 | 01691 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517004116.0 | ||
| 264 | 0 | _c20150803 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1879-1301 | ||
| 024 | 7 |
_a10.1016/j.chembiol.2014.09.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKohno, Masayuki | |
| 245 | 0 | 0 |
_aThe membrane-lytic peptides K8L9 and melittin enter cancer cells via receptor endocytosis following subcytotoxic exposure. _h[electronic resource] |
| 260 |
_bChemistry & biology _cNov 2014 |
||
| 300 |
_a1522-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aEndocytosis _xdrug effects |
| 650 | 0 | 4 |
_aHSC70 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoprecipitation |
| 650 | 0 | 4 |
_aLow Density Lipoprotein Receptor-Related Protein-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLysosomes _xdrug effects |
| 650 | 0 | 4 |
_aMelitten _xchemistry |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNeuropilin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Transferrin _xantagonists & inhibitors |
| 700 | 1 | _aHoribe, Tomohisa | |
| 700 | 1 | _aOhara, Koji | |
| 700 | 1 | _aIto, Shinji | |
| 700 | 1 | _aKawakami, Koji | |
| 773 | 0 |
_tChemistry & biology _gvol. 21 _gno. 11 _gp. 1522-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.chembiol.2014.09.008 _zAvailable from publisher's website |
| 999 |
_c24399178 _d24399178 |
||